09/29/2020
5:02 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2020
3:15 PM | Sorrento Therapeutics (Filer)
| Form DEFA14A
| |
09/17/2020
5:02 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2020
5:03 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2020
8:10 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/01/2020
4:11 PM | Sorrento Therapeutics (Filer)
| Form DEF 14A
| |
08/21/2020
4:26 PM | Sorrento Therapeutics (Filer)
| Form PRE 14A
| |
08/21/2020
3:48 PM | Asghar Najjam (Reporting)
Sorrento Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/18/2020
3:47 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2020
6:44 PM | Janda Kim (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
07/29/2020
8:01 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2020
8:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/20/2020
8:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2020
3:40 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2020
3:38 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/30/2020
3:36 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2020
5:11 PM | Shao Jiong (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:10 PM | SHAH JAISIM (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:10 PM | Lemus David (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:09 PM | Lee Edgar (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:09 PM | Followwill Dorman (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:09 PM | Sorrento Therapeutics (Issuer)
Wu Yue Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:08 PM | Janda Kim (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:08 PM | Ji Henry (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2020
5:08 PM | Smith Robin L (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2020
8:31 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2020
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2020
3:02 PM | Sorrento Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/27/2020
3:38 PM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
04/27/2020
3:38 PM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
04/27/2020
3:37 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2020
5:03 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2020
11:15 PM | Sorrento Therapeutics (Filer)
| Form EFFECT
| |
03/20/2020
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2020
3:41 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2020
12:58 PM | Smith Robin L (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/02/2020
8:57 PM | Sorrento Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2020
5:04 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2020
5:05 AM | Ally Bridge Group Capital Partners II, L.P. (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G/A
| |
02/10/2020
3:46 PM | Famous Sino Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G/A
| |
02/10/2020
3:45 PM | China In Shine Investment Ltd (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G/A
| |
01/29/2020
11:15 PM | Sorrento Therapeutics (Filer)
| Form EFFECT
| |
01/29/2020
3:45 PM | Sorrento Therapeutics (Filer)
| Form 424B3
| |
01/27/2020
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/24/2020
3:40 PM | Sorrento Therapeutics (Filer)
| Form S-3/A
| |
01/23/2020
11:15 PM | Sorrento Therapeutics (Filer)
| Form EFFECT
| |
01/22/2020
8:48 PM | Sorrento Therapeutics (Filer)
| Form S-3/A
| |
01/17/2020
4:08 PM | Sorrento Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/17/2020
3:17 PM | Sorrento Therapeutics (Filer)
| Form S-3/A
| |
01/10/2020
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/07/2020
4:02 PM | Sorrento Therapeutics (Filer)
| Form S-3/A
| |
12/18/2019
4:56 PM | Smith Robin L (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2019
4:51 PM | Smith Robin L (Reporting)
Sorrento Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/17/2019
4:25 PM | Sorrento Therapeutics (Filer)
| Form S-3/A
| |
12/11/2019
4:08 PM | Lee Edgar (Reporting)
Sorrento Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2019
4:06 PM | Lee Edgar (Reporting)
Sorrento Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/09/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/25/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2019
7:03 PM | Sorrento Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/13/2019
3:41 PM | Sorrento Therapeutics (Filer)
| Form CT ORDER
| |
10/09/2019
10:46 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2019
3:18 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2019
3:15 PM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
10/01/2019
3:32 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2019
3:28 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2019
3:26 PM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
10/01/2019
1:23 PM | Sorrento Therapeutics (Filer)
| Form CT ORDER
| |
09/25/2019
4:31 PM | OAKTREE CAPITAL MANAGEMENT LP (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13G
| |
09/23/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2019
5:06 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2019
4:19 PM | Sorrento Therapeutics (Filer)
| Form DEF 14A
| |
08/14/2019
12:39 PM | Sorrento Therapeutics (Filer)
| Form CT ORDER
| |
08/12/2019
9:10 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2019
9:07 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2019
3:49 PM | Sorrento Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/02/2019
3:49 PM | Sorrento Therapeutics (Filer)
| Form PRE 14A
| |
07/02/2019
11:52 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2019
11:15 PM | Sorrento Therapeutics (Filer)
| Form EFFECT
| |
07/01/2019
3:53 PM | Sorrento Therapeutics (Filer)
| Form 424B3
| |
06/28/2019
4:20 PM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
06/28/2019
4:17 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2019
5:06 AM | Sorrento Therapeutics (Subject)
| Form FWP
| |
06/28/2019
5:06 AM | Sorrento Therapeutics (Filer)
| Form 424B5
| |
06/20/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/19/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2019
3:40 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2019
3:28 PM | Sorrento Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
06/17/2019
8:22 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2019
3:46 PM | Sorrento Therapeutics (Filer)
| Form CT ORDER
| |
06/05/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2019
6:00 AM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2019
4:07 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2019
4:00 PM | Sorrento Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2019
9:41 AM | Sorrento Therapeutics (Filer)
| Form CT ORDER
| |
05/13/2019
3:02 PM | Sorrento Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2019
3:01 PM | Sorrento Therapeutics (Filer)
| Form NT 10-Q
| |
05/09/2019
4:14 PM | Opko Health, Inc. (Filed by)
Sorrento Therapeutics (Subject)
| Form SC 13D
| |
05/07/2019
11:15 PM | Sorrento Therapeutics (Filer)
| Form EFFECT
| |
05/07/2019
3:54 PM | Sorrento Therapeutics (Filer)
| Form 424B3
| |
